The concomitant usage of oxycodone HCl with all cytochrome P450 3A4 inhibitors may well end in an increase in oxycodone plasma concentrations, which could enhance or prolong adverse reactions and should trigger most likely fatal respiratory melancholy. Furthermore, discontinuation of a concomitantly